DAP:ETR
Danaher Corp
€203.30
arrow_downward
-0.64%(-1.30) 1D
Oct 19, 3:19:37 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
€204.00
High
€205.70
Low
€203.30
Mkt. cap
158.87B
Avg. vol.
494.00
Volume
251.00
52-wk high
€208.30
52-wk low
€138.20
No. of employees
59K
Open
€204.00
High
€205.70
Low
€203.30
Mkt. cap
158.87B
Avg. vol.
494.00
Volume
251.00
52-wk high
€208.30
52-wk low
€138.20
No. of employees
59K
News stories
From web sources and news partners
Benzinga
·
2 hours ago
Danaher Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
ad-hoc-news.de
·
8 hours ago
Danaher Corp. stock pre-market at EUR 204.75: life sciences group
Yahoo Finance
·
1 day ago
Roper Technologies (ROP) vs. Danaher (DHR): Which Is the Better Long-Term Capital Allocator?
Insider Monkey
·
2 days ago
Danaher’s Stock Is Pricing in a Recovery. Can Its Earnings Deliver?
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp